Dahlman-Wright_2

Research interests

The overall goal is the development of novel therapeutic strategies in type 2 diabetes (T2D) and breast cancer.

There is substantial evidence for the involvement of estrogen signaling and estrogen receptors (ERs) in T2D combined with a great unmet medical need for this disease. ERα knock-out (KO) mice are obese and display insulin resistance; however, the target tissues responsible for these effects remain elusive. Tissue-selective KO animals are well posed to address this issue and we have generated mice with ERα KO in hepatocytes, adipocytes and pancreatic β-cells and are correlating observed phenotypes with molecular details such as changes in gene expression profiles.

Estrogen signaling promotes breast cancer growth and ER antagonists represent first line therapy for ER positive breast cancer. However, all tumors do not respond to this therapy and additionally many tumors eventually acquire ER antagonist resistance supporting a need to develop novel therapeutic strategies. We are exploring several avenues to modulate estrogen signaling in breast cancer cells. The extensive cross talk between estrogen signaling and AP-1 signaling that we have described indicates a potential of modulators of AP-1 family in the management of ER positive breast cancer.

Triple negative breast cancer (TNBC), that do not express ERs, represent some of the most aggressive forms of breast cancer. We have shown that the AP-1 transcription factor component Fra-1 is overexpressed in basal-like breast tumors, and that its expression level has high prognostic significance. Depletion of Fra-1 or its heterodimeric partner c-Jun inhibits the proliferative and invasive phenotypes of TNBC cells in vitro and reduces cellular invasion in vivo. Exploring the AP-1 cistrome and the AP-1-regulated transcriptome, we provide insights into the transcriptional regulatory networks of AP-1 in TNBC cells, identifying direct targets of the Fra-1/c-Jun heterodimer involved in cell proliferation, cell adhesion, and cell-cell contact.

Group members

Hui Gao, Research assistant
Lucia Bialešová, Post doc
Lars-Arne Haldosén, Lecturer
Min Jia, Post doc
Amirhossein Kharman Biz, PhD-student
Yichun Qiao, PhD-student
Indranil Sinha, Post doc
Chunyan Zhao, Researcher
Jian Zhu, PhD-student

Contact

karin.dahlman-wright@scilifelab.se

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.